c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays (Q36609706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Emmanuelle Charafe-Jauffret

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

S Garcia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

J-P Dalès

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

J Jacquemier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

D Birnbaum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

L Andrac-Meyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M-N Lavaut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C Allasia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

S Carpentier-Meunier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

P Bonnier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C Charpin-Taranger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

329-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

Effector memory T cells, early metastasis, and survival in colorectal cancer

24 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Met, metastasis, motility and more

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

c-Met: structure, functions and potential for therapeutic inhibition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Tissue microarray technology for high-throughput molecular profiling of cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Expression of c-met is a strong independent prognostic factor in breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Expression of the C-Met/HGF receptor in human breast carcinoma: Correlation with tumor progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Inflammatory breast cancer: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Automated subcellular localization and quantification of protein expression in tissue microarrays.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359990

Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience

20 September 2018

1 reference

12 December 2020

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients

1 reference

12 December 2020

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

17242702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17242702%20AND%20SRC:MED&resulttype=core&format=json